AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PharmaCyte Biotech, Inc. Director's Dealing 2009

Mar 31, 2009

35351_dirs_2009-03-30_a27bfd5e-bc60-4177-87f9-7bb3786c0664.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NUVILEX, INC. (NVLX)
CIK: 0001157075
Period of Report: 2009-03-17

Reporting Person: BARNES MARYLEW (Director, CFO and Secretary)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.0001	121805	Direct